MeSH term
Frequency | Condition_Probility | Aflatoxin B1/metabolism | 3 | 37.0 |
Animals | 27 | 0.0 |
*Aryl Hydrocarbon Hydroxylases | 31 | 3.0 |
Catalysis | 7 | 0.0 |
English Abstract | 4 | 0.0 |
Humans | 88 | 0.0 |
Mice | 8 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Mice, Transgenic | 4 | 0.0 |
Mutagenicity Tests | 2 | 1.0 |
Adult | 20 | 0.0 |
Aged | 7 | 0.0 |
Middle Aged | 10 | 0.0 |
Comparative Study | 18 | 0.0 |
Enzyme Induction/drug effects | 3 | 0.0 |
Isoenzymes/metabolism | 5 | 0.0 |
Oxidoreductases, N-Demethylating/biosynthesis/*genetics | 2 | 25.0 |
Research Support, Non-U.S. Gov't | 48 | 0.0 |
Species Specificity | 5 | 0.0 |
Substrate Specificity | 7 | 0.0 |
Base Sequence | 20 | 0.0 |
Cytochrome P-450 Enzyme System/*genetics | 13 | 3.0 |
DNA Primers | 10 | 0.0 |
Gene Expression Regulation, Enzymologic | 8 | 1.0 |
Intestine, Small/*enzymology | 2 | 10.0 |
Liver/*enzymology | 3 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Promoter Regions (Genetics) | 4 | 0.0 |
Transcription, Genetic | 7 | 0.0 |
Aging/*metabolism | 6 | 2.0 |
Cytochrome P-450 Enzyme System/metabolism | 3 | 1.0 |
Pharmaceutical Preparations/*metabolism | 3 | 3.0 |
*Pharmacokinetics | 2 | 4.0 |
Adolescent | 5 | 0.0 |
Cytochrome P-450 Enzyme System/*biosynthesis/genetics | 13 | 18.0 |
Drug Interactions | 2 | 0.0 |
Enzyme Induction | 3 | 0.0 |
Female | 23 | 0.0 |
Male | 19 | 0.0 |
RNA, Messenger/*biosynthesis | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 19 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 7 | 0.0 |
Rifampin/*pharmacology | 2 | 4.0 |
Cytochrome P-450 Enzyme System/genetics/*metabolism | 4 | 2.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Microsomes/metabolism | 2 | 1.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Aryl Hydrocarbon Hydroxylases/*genetics | 2 | 1.0 |
Caco-2 Cells | 2 | 0.0 |
Calcitriol/*pharmacology | 2 | 1.0 |
Cytochrome P-450 Enzyme System/genetics | 2 | 1.0 |
Genes, Reporter | 2 | 0.0 |
Molecular Sequence Data | 20 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Transfection | 6 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Exons | 2 | 0.0 |
Oxidoreductases, N-Demethylating/*genetics | 5 | 11.0 |
Polymerase Chain Reaction | 11 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Biotransformation | 7 | 1.0 |
Chromatography, High Pressure Liquid | 6 | 0.0 |
Cytochrome P-450 Enzyme System/*metabolism | 12 | 2.0 |
In Vitro | 5 | 0.0 |
Stereoisomerism | 3 | 0.0 |
Child | 6 | 0.0 |
Fetus/metabolism | 2 | 1.0 |
Infant, Newborn | 4 | 0.0 |
Microsomes, Liver/enzymology/*metabolism | 2 | 2.0 |
Mixed Function Oxygenases/metabolism | 2 | 1.0 |
Cloning, Molecular | 5 | 0.0 |
*Gene Expression | 2 | 0.0 |
Gestational Age | 5 | 0.0 |
Immunoblotting | 3 | 0.0 |
Liver/*embryology/enzymology | 2 | 40.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Protein Binding | 5 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Cytochrome P-450 Enzyme System/*genetics/metabolism | 5 | 4.0 |
Gene Expression | 6 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
DNA, Complementary | 5 | 0.0 |
Rifampin/pharmacology | 3 | 4.0 |
Gene Expression Regulation, Enzymologic/*drug effects | 4 | 2.0 |
Mixed Function Oxygenases/genetics | 2 | 5.0 |
Molecular Weight | 3 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Fetus/enzymology | 4 | 14.0 |
Tissue Distribution | 4 | 0.0 |
Fetus | 7 | 1.0 |
Kinetics | 9 | 0.0 |
Troleandomycin/pharmacology | 4 | 6.0 |
Fetus/*enzymology | 3 | 21.0 |
Fetus/*metabolism | 2 | 2.0 |
*Embryonic and Fetal Development | 2 | 1.0 |
Oxidation-Reduction | 3 | 0.0 |
Blotting, Western | 8 | 0.0 |
Cross Reactions | 2 | 0.0 |
Ketoconazole/pharmacology | 2 | 2.0 |
Microsomes, Liver/metabolism | 2 | 1.0 |
Rats | 5 | 0.0 |
Testosterone/metabolism | 4 | 3.0 |
Cell Line | 5 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Aryl Hydrocarbon Hydroxylases/metabolism | 3 | 6.0 |
Microsomes, Liver/enzymology | 5 | 2.0 |
Nifedipine/metabolism | 2 | 11.0 |
Polymorphism, Genetic | 2 | 0.0 |
Antibody Specificity | 2 | 0.0 |
Cells, Cultured | 8 | 0.0 |
Hydroxylation | 4 | 1.0 |
Liver/embryology/enzymology/growth & development | 2 | 66.0 |
Pregnancy | 7 | 0.0 |
Xenobiotics/metabolism | 2 | 4.0 |
Intestine, Small/enzymology | 2 | 12.0 |
Transgenes | 2 | 0.0 |
Dehydroepiandrosterone/metabolism | 3 | 16.0 |
Microsomes/enzymology | 2 | 1.0 |
Steroid 16-alpha-Hydroxylase | 3 | 21.0 |
Child, Preschool | 4 | 0.0 |
Infant | 4 | 0.0 |
Liver/enzymology | 3 | 0.0 |
Xenobiotics/*metabolism | 2 | 3.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Endometrium/*enzymology | 3 | 27.0 |
Embryonic and Fetal Development | 2 | 0.0 |
Liver/embryology/*enzymology | 4 | 36.0 |
Aryl Hydrocarbon Hydroxylases/*biosynthesis/genetics | 3 | 18.0 |
Dexamethasone/pharmacology | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
RNA, Messenger/biosynthesis | 5 | 0.0 |
Guinea Pigs | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Cytochrome P-450 Enzyme System/*biosynthesis/metabolism | 2 | 15.0 |
*Gene Expression Regulation, Developmental | 3 | 0.0 |
Microsomes, Liver/*enzymology | 3 | 1.0 |
Mixed Function Oxygenases/*genetics | 3 | 2.0 |
*Gene Expression Regulation, Enzymologic | 4 | 0.0 |
Cytochrome P-450 Enzyme System/*analysis/genetics | 2 | 25.0 |
Mixed Function Oxygenases/*analysis/genetics | 2 | 40.0 |
Smoking | 2 | 0.0 |
Liver/metabolism | 2 | 0.0 |
CHO Cells | 2 | 0.0 |
Hamsters | 6 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
RNA, Messenger/*analysis | 2 | 0.0 |
Analysis of Variance | 2 | 0.0 |
Placenta/*enzymology | 3 | 3.0 |
Cytochrome P-450 CYP2E1 | 4 | 3.0 |
Microsomes/*enzymology | 3 | 6.0 |
Midazolam/metabolism | 2 | 10.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Multigene Family | 3 | 0.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Cricetulus | 2 | 0.0 |
Benzoflavones/pharmacology | 2 | 4.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Aryl Hydrocarbon Hydroxylases/*metabolism | 3 | 6.0 |
Time Factors | 2 | 0.0 |
Isoenzymes/biosynthesis/genetics | 3 | 6.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
